The BD Prevue™ II Peripheral Vascular Access System reportedly offers real-time needle depth markers that may reduce multiple needlestick attempts and allow easier placement of intravenous (IV) access in high-risk patients.
Could an emerging ultrasound guidance modality make challenging IV (intravenous) access a thing of the past for hospitalized patients?
Recognizing the frequent challenges with vessel visualization and access for IV placement in hospitalized patients, BD (Becton, Dickinson and Company) has launched the BD Prevue™ II Peripheral Vascular Access System, an ultrasound guidance modality that may improve the efficiency and safety of needlesticks for IV access.
BD said key features of the BD Prevue II Vascular Access System include:
• real-time needle depth markers;
• a specialized probe, which allows use of the technology without the clinician altering his or her field of view or current insertion technique;
• a virtual display of the needle trajectory with BD Cue™ Needle Tracking Technology; and
• vessel assessment tools that help ensure optimal IV catheter length.
“Difficult IV access remains far too common today, but the availability of the BD Prevue II (Vascular Access) System supports a future where every needle stick has a predefined pathway for successful placement,” noted Eric Borin, the worldwide president of Medication Delivery Solutions at BD. “ … First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence.”
BD added the BD Prevue Vascular Access System is compatible with BD Cue Needle Tracking-enabled catheters.
(Editor’s note: For a related article, see “Intravascular Ultrasound for Lower Extremity Interventions: Seven Takeaways for New Global Consensus Recommendations.”)
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.